LivePerson Investor’s WildHealth Appeal Yields Chance to Replead

A LivePerson Inc. investor came up short in alleging the messaging company misrepresented the prospects of its WildHealth subsidiary but can refile his claims, the Second Circuit ruled Tuesday.

The district court judge didn’t have Noam Damri’s new witness materials before him when he concluded that it would be futile for the shareholder to amend his complaint, the US Court of Appeals for the Second Circuit said in an unsigned, unpublished ruling.

• Damri alleged LivePerson acquired healthcare service WildHealth in February 2022 but later received notice—and concealed—that Medicare would no longer offer reimbursements for the unit’s Covid-19 testing program
• The ...